Skip to Content
Merck
CN
  • Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity.

Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity.

Archives of pharmacal research (1999-03-11)
D H Kim, K T Lee, E A Bae, M J Han, H J Park
ABSTRACT

When liriodendrin or syringin was incubated for 24 h with human intestinal bacteria, two metabolites, (+)-syringaresinol-beta-D-glucopyranoside and (+)-syringaresinol, from liriodendrin and one metabolite, synapyl alcohol, from syringin were produced. The metabolic time course of liriodendrin was as follows: at early time, liriodendrin was converted to (+)-syringaresinol-beta-D-glucopyranoside, and then (+)-syringaresinol. The in vitro cytotoxicities of these metabolites, (+)-syringaresinol and synapyl alcohol, were superior to those of liriodendrin and syringin.

MATERIALS
Product Number
Brand
Product Description

Supelco
Eleutheroside E, analytical standard